[Forbes]
Human Genome Sciences lupus drug met study goal - AP , 07.20.09, 07:31 AM EDT NEW YORK -- Human Genome Sciences Inc. said Monday its drug candidate Benlysta reduced the symptoms of lupus in a late stage clinical trial, and was more effective than a placebo. The company said a combination of Benlysta and standard treatment was superior to ...